ATPW
NVAX icon

Ashton Thomas Private Wealth’s Novavax NVAX Stock Holding History

Ashton Thomas Private Wealth’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-40,571
Closed -$273K – 1539
2025
Q4 		$273K Sell
40,571
-567
-1% -$4.27K 0.01% 849
2025
Q3 		$357K Buy
+41,138
New +$320K 0.01% 732

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ashton Thomas Private Wealth's NVAX Position: Q1 2026 in Review

Ashton Thomas Private Wealth sold out of Novavax (NVAX) in Q1 2026, closing a stake of 40,571 shares — an estimated $273K sold.

Ashton Thomas Private Wealth first reported a position in NVAX in Q3 2025 and held it in 2 quarters. The position peaked at $357K in Q3 2025. 259 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Ashton Thomas Private Wealth reported no remaining Novavax position as of Q1 2026 after selling out during the quarter.
  • Ashton Thomas Private Wealth sold 40,571 Novavax shares in Q1 2026, an estimated $273K.
  • Ashton Thomas Private Wealth first reported a position in Novavax in Q3 2025 and held it in 2 quarters.
  • Ashton Thomas Private Wealth's Novavax position peaked at $357K in Q3 2025.
  • 259 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Ashton Thomas Private Wealth's 13F filing for Q1 2026, filed 11 May 2026.